Metabolism and cardiac actions of a polar aminocardenolide and digoxin in the conscious dog

E. Songu Mize, C. B. Nash, J. T. Elam, Robert William Caldwell

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We studied the metabolism and cardiac actions of a polar aminocardenolide, 3-β-O-(4-amino-4,6-dideoxy-β-D-galactopyranosyl) digitoxigenin (ASI-222), in conscious, chronically instrumented dogs and compared the cardiac actions of this compound with those of digoxin. Chloroform-soluble metabolites and the excretion patterns of ASI-222 in urine and feces were identified and measured using thin-layer chromatography. The deaminated metabolites of ASI-222 appeared both in the urine and the feces together with the genin, digitoxigenin and the parent drug which constituted the majority of the radioactivity excreted. There was a secondary rise in the plasma concentration of ASI-222 starting 2 hr after the i.v. administration, which strongly suggests its enterohepatic recycling. The secondary increase in the plasma concentration was not seen in the dogs receiving digoxin. ASI-222 produced increases in cardiac contractility and systolic blood pressure which were more rapid in onset and shorter in duration than those produced by an equimolar dose of digoxin. Amplitudes of these physiologic responses to these two compounds in conscious dogs were approximately 2 times higher than the effects previously reported to similar doses in anesthetized dogs.

Original languageEnglish (US)
Pages (from-to)65-70
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume226
Issue number1
StatePublished - Jan 1 1983
Externally publishedYes

Fingerprint

Digoxin
Dogs
Digitoxigenin
Feces
Urine
Blood Pressure
Thin Layer Chromatography
Chloroform
Radioactivity
ASI-222
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Metabolism and cardiac actions of a polar aminocardenolide and digoxin in the conscious dog. / Songu Mize, E.; Nash, C. B.; Elam, J. T.; Caldwell, Robert William.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 226, No. 1, 01.01.1983, p. 65-70.

Research output: Contribution to journalArticle

@article{1acbce90740a4a369dc78f35a2c2c977,
title = "Metabolism and cardiac actions of a polar aminocardenolide and digoxin in the conscious dog",
abstract = "We studied the metabolism and cardiac actions of a polar aminocardenolide, 3-β-O-(4-amino-4,6-dideoxy-β-D-galactopyranosyl) digitoxigenin (ASI-222), in conscious, chronically instrumented dogs and compared the cardiac actions of this compound with those of digoxin. Chloroform-soluble metabolites and the excretion patterns of ASI-222 in urine and feces were identified and measured using thin-layer chromatography. The deaminated metabolites of ASI-222 appeared both in the urine and the feces together with the genin, digitoxigenin and the parent drug which constituted the majority of the radioactivity excreted. There was a secondary rise in the plasma concentration of ASI-222 starting 2 hr after the i.v. administration, which strongly suggests its enterohepatic recycling. The secondary increase in the plasma concentration was not seen in the dogs receiving digoxin. ASI-222 produced increases in cardiac contractility and systolic blood pressure which were more rapid in onset and shorter in duration than those produced by an equimolar dose of digoxin. Amplitudes of these physiologic responses to these two compounds in conscious dogs were approximately 2 times higher than the effects previously reported to similar doses in anesthetized dogs.",
author = "{Songu Mize}, E. and Nash, {C. B.} and Elam, {J. T.} and Caldwell, {Robert William}",
year = "1983",
month = "1",
day = "1",
language = "English (US)",
volume = "226",
pages = "65--70",
journal = "The Journal of pharmacology and experimental therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Metabolism and cardiac actions of a polar aminocardenolide and digoxin in the conscious dog

AU - Songu Mize, E.

AU - Nash, C. B.

AU - Elam, J. T.

AU - Caldwell, Robert William

PY - 1983/1/1

Y1 - 1983/1/1

N2 - We studied the metabolism and cardiac actions of a polar aminocardenolide, 3-β-O-(4-amino-4,6-dideoxy-β-D-galactopyranosyl) digitoxigenin (ASI-222), in conscious, chronically instrumented dogs and compared the cardiac actions of this compound with those of digoxin. Chloroform-soluble metabolites and the excretion patterns of ASI-222 in urine and feces were identified and measured using thin-layer chromatography. The deaminated metabolites of ASI-222 appeared both in the urine and the feces together with the genin, digitoxigenin and the parent drug which constituted the majority of the radioactivity excreted. There was a secondary rise in the plasma concentration of ASI-222 starting 2 hr after the i.v. administration, which strongly suggests its enterohepatic recycling. The secondary increase in the plasma concentration was not seen in the dogs receiving digoxin. ASI-222 produced increases in cardiac contractility and systolic blood pressure which were more rapid in onset and shorter in duration than those produced by an equimolar dose of digoxin. Amplitudes of these physiologic responses to these two compounds in conscious dogs were approximately 2 times higher than the effects previously reported to similar doses in anesthetized dogs.

AB - We studied the metabolism and cardiac actions of a polar aminocardenolide, 3-β-O-(4-amino-4,6-dideoxy-β-D-galactopyranosyl) digitoxigenin (ASI-222), in conscious, chronically instrumented dogs and compared the cardiac actions of this compound with those of digoxin. Chloroform-soluble metabolites and the excretion patterns of ASI-222 in urine and feces were identified and measured using thin-layer chromatography. The deaminated metabolites of ASI-222 appeared both in the urine and the feces together with the genin, digitoxigenin and the parent drug which constituted the majority of the radioactivity excreted. There was a secondary rise in the plasma concentration of ASI-222 starting 2 hr after the i.v. administration, which strongly suggests its enterohepatic recycling. The secondary increase in the plasma concentration was not seen in the dogs receiving digoxin. ASI-222 produced increases in cardiac contractility and systolic blood pressure which were more rapid in onset and shorter in duration than those produced by an equimolar dose of digoxin. Amplitudes of these physiologic responses to these two compounds in conscious dogs were approximately 2 times higher than the effects previously reported to similar doses in anesthetized dogs.

UR - http://www.scopus.com/inward/record.url?scp=0020559929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020559929&partnerID=8YFLogxK

M3 - Article

C2 - 6864551

AN - SCOPUS:0020559929

VL - 226

SP - 65

EP - 70

JO - The Journal of pharmacology and experimental therapeutics

JF - The Journal of pharmacology and experimental therapeutics

SN - 0022-3565

IS - 1

ER -